| Literature DB >> 23466743 |
Himen Salimizand1, Fereshteh Shahcheraghi, Enayatollah Kalantar, Farzad Badmasti, Seyed Fazlollah Mousavi.
Abstract
BACKGROUND AND OBJECTIVES: Klebsiella species are of the most common bacteria involved in nosocomial and urinary tract infections. Genetic elements such as class 1 integrons have an important role in the resistance development. In this study, the share of class 1 integrons, the genetic characterization of the integron cassettes and PFGE profiles of the clinical Klebsiella isolates are evaluated in Besat University hospital of Sanandaj, Iran.Entities:
Keywords: Klebsiella spp.; class 1 integrons; multidrug resistante (MDR)
Year: 2013 PMID: 23466743 PMCID: PMC3577558
Source DB: PubMed Journal: Iran J Microbiol ISSN: 2008-3289
Klebsiella isolates and source of isolation.
| Source |
|
| ||
|---|---|---|---|---|
|
| ||||
| Non-MDR | MDR | Non-MDR | MDR | |
|
| 4 | 9 | 3 | 3 |
|
| 1 | 1 | 0 | 0 |
|
| 0 | 9 | 0 | 0 |
|
| 2 | 1 | 0 | 0 |
|
| 1 | 0 | 0 | 0 |
|
| 9 | 20 | 3 | 3 |
Abbreviation: MDR, multidrug resistant; non-MDR, non multidrug resistant.
Antibiotic profile of all Klebsiella spp. isolated in this study.
| Susceptible no. (%) | Intermediate no. (%) | Resistant no. (%) | |
|---|---|---|---|
|
| 35(100) | 0 (0) | 0 (0) |
|
| 35(100) | 0 (0) | 0 (0) |
|
| 7(20) | 0 (0) | 28(80) |
|
| 7(20) | 0 (0) | 28(80) |
|
| 6(17) | 0 (0) | 29(83) |
|
| 7(20) | 0 (0) | 28(80) |
|
| 11(31) | 3(8) | 21(61) |
|
| 11(31) | 4(11) | 20(58) |
|
| 13(37) | 4(11) | 18(52) |
|
| 7(20) | 0 (0) | 28(80) |
Abbreviations: IMI, imipenem; MEM, meropenem; CAZ, ceftazidime; CTX, cefotaxime; CRO, ceftriaxone; CPM, cefepime; CIP, ciprofloxacin; GM, gentamicin; AK, amikacin; ATM, aztreonam.
Characteristics of integrons and their integrated gene cassettes identified in the integron-carrying MDR Klebsiella spp. isolates.
| MDR Isolates name | Isolation source | Ward of isolation | MIC(µg mL−1) | Length of IVRs (bp) | Integron gene cassettes | ||
|---|---|---|---|---|---|---|---|
|
| |||||||
| CIP | CAZ | GM | |||||
| HSZKP1 | W/C | ICU2 | 2 | 64 | 32 | 400, 800 | arr-5 / aacA4-orfD |
| HSZKP2 | U/ C | IM | 64 | 128 | 64 | 400, 800, 2300 | arr-5 / aacA4-orfD / dfrA17-aadA5 |
| HSZKP3 | Tr | ICU1 | 4 | 64 | 32 | 400, 800, 2300 | arr-5 / aacA4-orfD / dfrA17-aadA5 |
| HSZKO6 | U/C | E | <0.25 | 1 | 1 | 400, 800 | arr-5 / aacA4-orfD |
| HSZKO7 | U/C | OP | <0.25 | <0.5 | <0.5 | 800 | aacA4-orfD |
| HSZKP8 | U/C | ICU2 | <0.25 | 16 | 2 | 800, 2300 | arr-5 / aacA4-orfD / dfrA17-aadA5 |
| HSZKP9 | Tr | ICU2 | 4 | 32 | 8 | 400, 800, 2300 | arr-5 / aacA4-orfD / dfrA17-aadA5 |
| HSZKP19 | U/C | ICU2 | 0.25 | 32 | 8 | 400, 800, 2300 | arr-5 / aacA4-orfD / dfrA17-aadA5 |
| HSZKP32 | Tr | ICU2 | 4 | 128 | 64 | 400, 800, 2300 | arr-5 / aacA4-orfD / dfrA17-aadA5 |
| HSZKP33 | Tr | ICU1 | 2 | 128 | 64 | 400, 800, 2300 | arr-5 / aacA4-orfD / dfrA17-aadA5 |
| HSZKP43 | Tr | ICU2 | 4 | 16 | 32 | 400, 800, 2300 | arr-5 / aacA4-orfD / dfrA17-aadA5 |
| HSZKP44 | Tr | ICU1 | 2 | 256 | 128 | 400, 800 | arr-5 / aacA4-orfD |
| HSZKP45 | U/ C | ICU1 | 2 | 32 | 8 | 400, 800, 2300 | arr-5 / aacA4-orfD / dfrA17-aadA5 |
| HSZKP54 | Tr | ICU2 | <0.25 | 128 | 32 | 400, 800, 2300 | arr-5 / aacA4-orfD / dfrA17-aadA5 |
| HSZKP71 | U/ C | E | 8 | 128 | 16 | 400, 800, 2300 | arr-5 / aacA4-orfD / dfrA17-aadA5 |
| HSZKP89 | U/C | OP | 32 | 16 | 4 | 400, 800, 2300 | arr-5 / aacA4-orfD / dfrA17-aadA5 |
| HSZKP90 | Tr | NS | 32 | 128 | 64 | 400, 800, 2300 | arr-5 / aacA4-orfD / dfrA17-aadA5 |
| HSZKP91 | Tr | ICU1 | 32 | 256 | 64 | 400, 800, 2300 | arr-5 / aacA4-orfD / dfrA17-aadA5 |
| HSZKP93 | W/C | PICU | <0.25 | 16 | 2 | 400, 800 | arr-5 / aacA4-orfD |
| HSZKP95 | U/C | OP | 1 | 2 | 1 | 400, 800 | arr-5 / aacA4-orfD |
| HSZKP96 | BS/C | OP | 0.5 | 16 | 8 | 400, 800, 2300 | arr-5 / aacA4-orfD / dfrA17-aadA5 |
| HSZKP97 | B/C | PICU | <0.25 | 2 | 2 | 400, 800 | arr-5 / aacA4-orfD |
| HSZKO98 | U/C | ICU1 | <0.25 | 2 | 0.5 | 800 | aacA4-orfD |
Abbreviations resistance criteria: W/C, Wound culture; U/C, Urine culture; Tr, Trachea; BS/C, Brain shunt culture; B/C, Blood culture; IVRs, internal variable regions; ICU, Intensive Care Unit; PICU, Pediatrics Intensive Care Unit; OP, Outpatient; E, Elective; IM, Internal Medicine; NS, Neurosurgery. K. p, Klebsiella pneumonia; K. oxy, Klebsiella oxytoca; Break points for MIC: CIP= susceptible (≤1 µg mL−1), intermediate (2 µg mL−1) & resistant (≥4 µg mL−1); CAZ = susceptible (≤4 µg mL−1), intermediate (8 µg mL−1) & resistant (≥16 µg mL−1); GM= susceptible (≤4 µg mL−1), intermediate (8 µg mL−1) & resistant (≥16 µg mL−1).
Fig. 1PFGE typing of MDR K. pneumoniae isolates with XbaI. 18 clusters of MDR K. pneumoniae isolates were distinguished by dendrogram (Gelcompare II software). Abbreviations: ICU, Intensive Care Unit; PICU, Pediatrics Intensive Care Unit; OP, Outpatient; E, Elective; IM, Internal Medicine; NS, Neurosurgery.